SEC 13F Intelligence

Point72 Middle East Fze / VRTX

Point72 Middle East Fze’s Vertex Pharmaceuticals Inc Position

Does Point72 Middle East Fze own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 32.3K shares worth $11M in Q3 2023; the fund’s latest 13F (Q3 2025) no longer reports it.

Position Value
$11M
Q3 2023
Shares
32.3K
% of Portfolio
+0.37%
Quarters Held
3
position exited

Position History VRTX

Reported value by quarter
Q4 ’22: $10MQ4 ’22Q1 ’23: $5,041Q1 ’23Q3 ’23: $11MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202332.3K$11M+0.37%
Q1 202316$5,0410.00%
Q4 202233.2K$10M+0.42%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Point72 Middle East Fze’s full portfolio or all institutional holders of VRTX.